CSIMarket
 

Therapeuticsmd Inc   (TXMD)
Other Ticker:  
 

Therapeuticsmd Inc 's Working Capital Per Sales

TXMD's Working Capital and Revenue growth



TXMD Working Capital Per Revenue (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Working Capital Change - - - - -
Y / Y Revenue Change - -98.47 % -97.85 % -93.83 % -17.67 %
Working Capital Per Revenue 2.83 -0.5 -0.57 -1.08 -
Total Ranking # 2930 # 173 # 174 # 155 # 134
Seq. Working Capital Change -44.2 % -2.78 % -36.57 % - -
Seq. Revenue Change - 5.05 % -63.89 % -94.49 % -26.76 %





Comment on TXMD's Working Capital Per Revenue in the third quarter 2023
Therapeuticsmd Inc 's Working Capital Per Revenue sequentially grew to 2.83 during the Q3 2023, below the Therapeuticsmd Inc average. Due to increase of revenue in the Q3 2023 year on year by -100.25%.

Within Healthcare sector 90 other companies have achieved lower Working Capital Per Revenue during the Q3 2023. While Working Capital Per Revenue total ranking has deteriorated in the third quarter 2023, compared to previous quarter from 173 to 2930.
Working Capital Per Revenue Ranking
Within: No.
Industry # 30
Sector # 91
S&P 500 # 2930


Working Capital Per Revenue Statistics
High Average Low
9.86
3.84
-1.33
(Dec 31 2018)   (Sep 30 2022)



Financial Statements
Therapeuticsmd Inc 's Working Capital $ 3 Millions Visit TXMD's Balance sheet
Therapeuticsmd Inc 's Revenues $ 0 Millions Visit TXMD's Income Statement
Where are TXMD's Sales coming from? Visit TXMD's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Sep 30 2023, within Healthcare Sector Working Capital Per Revenue
Abeona Therapeutics Inc   7.74 
Foghorn Therapeutics Inc   7.74 
Caribou Biosciences Inc   7.26 
Dermtech Inc   7.07 
Hcw Biologics Inc   7.01 
Innovative Eyewear Inc   6.90 
Aclaris Therapeutics Inc   6.78 
Arcus Biosciences Inc   6.68 
Delcath Systems Inc   6.64 
Curis Inc   6.61 
Arcutis Biotherapeutics Inc   6.33 
Bluebird Bio Inc   6.30 
Nighthawk Biosciences inc   6.29 
Marinus Pharmaceuticals Inc   6.13 
Somalogic Inc   6.11 
Sutro Biopharma Inc   6.08 
Rewalk Robotics Ltd   6.03 
Aadi Bioscience Inc   5.94 
Maxcyte inc   5.83 
Alector Inc   5.69 
Arbutus Biopharma Corp  5.62 
Zevra Therapeutics Inc   5.59 
Inspiremd Inc   5.59 
Rapid Micro Biosystems Inc   5.51 
Zomedica Corp   5.42 
Merus N v   5.30 
Cara Therapeutics inc   5.28 
Hookipa Pharma inc   5.21 
Orchard Therapeutics Plc  5.14 
Mersana Therapeutics Inc   5.08 
Date modified: 2023-11-16T16:42:28+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com